Rick A Bright

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
    Rick A Bright
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Influenza Branch, Atlanta, GA, USA
    Lancet 366:1175-81. 2005
  2. pmc Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method
    Varough M Deyde
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Antimicrob Agents Chemother 53:1039-47. 2009
  3. pmc Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
    Tiffany G Sheu
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Antimicrob Agents Chemother 52:3284-92. 2008
  4. ncbi request reprint Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide
    Varough M Deyde
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 196:249-57. 2007
  5. ncbi request reprint Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
    Rick A Bright
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Influenza Branch, Atlanta, GA, USA
    JAMA 295:891-4. 2006
  6. doi request reprint Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response
    Taronna R Maines
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Immunol Rev 225:68-84. 2008
  7. ncbi request reprint Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice
    Hualan Chen
    Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road, N E, MS G16, Atlanta, GA 30333, USA
    Virus Res 128:159-63. 2007
  8. pmc Adamantane-resistant influenza infection during the 2004-05 season
    Mahbubur Rahman
    Epidemiology Research Center ML2, Marshfield Clinic Research Foundation, 1000 N Oak Avenue, Marshfield, WI 54449, USA
    Emerg Infect Dis 14:173-6. 2008
  9. ncbi request reprint Transmission of equine influenza virus to dogs
    P C Crawford
    College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA
    Science 310:482-5. 2005
  10. ncbi request reprint Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins
    Judy A Mitchell
    Department of Microbiology and Immunology, School of Medicine, East Carolina University, Brody Health Sciences Building, Room 5N 96E, 600 Moye Boulevard, Greenville, NC 27858 4354, USA
    Vaccine 21:902-14. 2003

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
    Rick A Bright
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Influenza Branch, Atlanta, GA, USA
    Lancet 366:1175-81. 2005
    ..We sought to assess adamantane resistance among influenza A viruses isolated during the past decade from countries participating in WHO's global influenza surveillance network...
  2. pmc Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method
    Varough M Deyde
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Antimicrob Agents Chemother 53:1039-47. 2009
    ..The pyrosequencing approach may provide a valuable tool for rapid detection of markers of drug resistance in H5N1 viruses and facilitate the elucidation of the role of such changes in natural and acquired drug resistance...
  3. pmc Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
    Tiffany G Sheu
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Antimicrob Agents Chemother 52:3284-92. 2008
    ..6% (50/579 isolates). The recent increase in oseltamivir resistance among A(H1N1) viruses isolated from untreated patients raises public health concerns and necessitates close monitoring of resistance to NA inhibitors...
  4. ncbi request reprint Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide
    Varough M Deyde
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 196:249-57. 2007
    ..The results of the study highlight the necessity of close monitoring of resistance to existing antivirals as wells as the need for new therapeutics...
  5. ncbi request reprint Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
    Rick A Bright
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Influenza Branch, Atlanta, GA, USA
    JAMA 295:891-4. 2006
    ..Rates of viruses resistant to these drugs have been increasing globally. Rapid surveillance for the emergence and spread of resistant viruses has become critical for appropriate treatment of patients...
  6. doi request reprint Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response
    Taronna R Maines
    Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Immunol Rev 225:68-84. 2008
    ..This review focuses on avian influenza viruses as a pandemic threat, their induction of host innate immune responses in mammalian species, and the contribution of these responses to the disease process...
  7. ncbi request reprint Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice
    Hualan Chen
    Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road, N E, MS G16, Atlanta, GA 30333, USA
    Virus Res 128:159-63. 2007
    ..Multiple genes are involved in virulence of Hong Kong H5N1 influenza A viruses for mice with the presence of lysine at aa627 in the PB2 gene exhibiting a significantly larger effect than the HA and NA genes...
  8. pmc Adamantane-resistant influenza infection during the 2004-05 season
    Mahbubur Rahman
    Epidemiology Research Center ML2, Marshfield Clinic Research Foundation, 1000 N Oak Avenue, Marshfield, WI 54449, USA
    Emerg Infect Dis 14:173-6. 2008
    ..Resistant and susceptible viruses caused similar symptoms and illness duration. The prevalence of resistance was highest in children...
  9. ncbi request reprint Transmission of equine influenza virus to dogs
    P C Crawford
    College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA
    Science 310:482-5. 2005
    ..Evidence of infection in pet dogs suggests that this infection may also become enzootic in this population...
  10. ncbi request reprint Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins
    Judy A Mitchell
    Department of Microbiology and Immunology, School of Medicine, East Carolina University, Brody Health Sciences Building, Room 5N 96E, 600 Moye Boulevard, Greenville, NC 27858 4354, USA
    Vaccine 21:902-14. 2003
    ..The HA-mC3d(3)-DNA vaccinated mice were protected from heterologous influenza challenge, even though sera from these mice had no viral-neutralizing activity against heterologous virus...